Novavax initiated with a Buy at BTIG
BTIG initiated coverage of Novavax (NVAX) with a Buy rating and $19 price target The company’s standalone COVID vaccine seems to be a ...
Stocks could see near-term bounce, but don't be fooled: BTIG's Krinsky
The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...
Health Catalyst price target lowered to $10 from $13 at BTIG
BTIG analyst David Larsen lowered the firm’s price target on Health Catalyst (HCAT) to $10 from $13 and keeps a Buy rating on the shares after ...
BTIG downgrades General Dynamics on Gulfstream supply chain, certification
BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain ...
Hosted on MSN21d
BTIG maintains $91 target on Globus Medical stock post-acquisition
Despite the unexpected move, analysts from BTIG consider the purchase a low-risk investment given the relatively small cash outlay. The acquisition is seen as an opportunity for Globus Medical to ...
S&P 500's technical set-up suggests a short-term bounce, says BTIG's Krinsky
The S&P 500's latest sell-off took it back to its February lows of 5923, notes Jonathan Krinsky, BTIG's technical guru. That's left it in danger of breaking below the uptrend from last summer's low.
Yahoo Finance7d
BTIG upgrades Snowflake to 'buy' on improving demand
Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...
Morningstar23d
BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 11 - 12, 2025
For more information about the conference, email uscorporateaccess@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative ...
Nasdaq2mon
BTIG Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation
As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...
Yahoo Finance1mon
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...
Rithm Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
Rithm Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of entering into a ...
Yahoo Finance7d
BTIG upgrades Snowflake to 'buy' on improving demand
Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted that ...